Prognostic factors in chronic myeloid leukemia: allografting
A Gratwohl - Seminars in hematology, 2003 - Elsevier
… outcomes—leukemia-free survival (LFS) and survival. Some … (CML) has been the most
frequent single indication for … complete molecular remissions with full donor chimerism.22, 23 …
frequent single indication for … complete molecular remissions with full donor chimerism.22, 23 …
Three decades of transplantation for chronic myeloid leukemia: what have we learned?
… bone marrow transplantation from a volunteer unrelated … who achieved a partial chimerism
lasting 6 years. As the use … of unrelated donor cells and reported a 5-year survival of 53% with …
lasting 6 years. As the use … of unrelated donor cells and reported a 5-year survival of 53% with …
[HTML][HTML] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
… status, bone marrow fibrosis, spleen size, donor chimerism, … differences in relapse-free
survival (RFS) and overall survival (… identified as indicators of measurable residual disease and …
survival (RFS) and overall survival (… identified as indicators of measurable residual disease and …
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre …
JE Wagner, JS Thompson, SL Carter, NA Kernan - The Lancet, 2005 - thelancet.com
… defined as the minimum time to relapse, death, or last follow-up. For all … or blood as detected
by a chimerism assay. … Bone marrow transplantation for chronic myelogenous leukemia in …
by a chimerism assay. … Bone marrow transplantation for chronic myelogenous leukemia in …
Chimerism Analysis of Children with Allogeneic Stem-Cell transplantation and Its Effect on Survival.
H Tekgüç, S Aksoylar, DC Tekgüç… - Cyprus Journal of …, 2022 - search.ebscohost.com
… , mixed chimerism levels may affect the event free survival (… the first 100-day donor chimerism
ratios and to search for a … within the first 100 days was the most important predictor of EFS. …
ratios and to search for a … within the first 100 days was the most important predictor of EFS. …
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses
R Childs, E Clave, N Contentin… - Blood, The Journal …, 1999 - ashpublications.org
… to correlate chimerism with major transplant outcomes and to measure … ; 3 had chronic
myelogenous leukemia [CML], 2 in chronic … received an autologous bone marrow transplant (BMT) …
myelogenous leukemia [CML], 2 in chronic … received an autologous bone marrow transplant (BMT) …
Is peripheral blood or bone marrow a better source of stem cells for transplantation in cases of HLA-matched unrelated donors? A meta-analysis
S Wu, C Zhang, X Zhang, Y Xu, T Deng - Critical reviews in oncology …, 2015 - Elsevier
… marrow transplantation (PBSCT and BMT). … acute or chronic GVHD but with a better
disease-free survival (DFS), … acute leukemia in 3, chronic myeloid leukemia in 1, and severe …
disease-free survival (DFS), … acute leukemia in 3, chronic myeloid leukemia in 1, and severe …
… haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a …
Michallet, Tanguy, Socié, Thiébaut… - British journal of …, 2000 - Wiley Online Library
… leukaemia (n = 47) or chronic myeloid leukaemia (n = 42) … influence overall survival (OS)
and disease-free survival (DFS) … infusion of donor lymphocytes, where we observed a complete …
and disease-free survival (DFS) … infusion of donor lymphocytes, where we observed a complete …
Allogeneic stem cell transplantation for chronic myeloid leukemia
J Barrett - Seminars in hematology, 2003 - Elsevier
… Bone Marrow Transplant Registry (IBMTR) analyzed relapse … mixed donor-host lymphoid
chimerism and relapse in CML. … 40 years have a lower disease-free survival (DFS). Delaying …
chimerism and relapse in CML. … 40 years have a lower disease-free survival (DFS). Delaying …
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced …
C Pfrepper, A Klink, G Behre, T Schenk… - Journal of cancer …, 2016 - Springer
… -free survival (EFS) was defined as time from HCT to relapse, … strongest predictor for a better
outcome was a donor chimerism … by whole bone marrow donor chimerism 2–4 weeks post-…
outcome was a donor chimerism … by whole bone marrow donor chimerism 2–4 weeks post-…